Read our monthly recap of some of the biggest FDA-related stories that have hit cardiology, including updates related to Cytokinetics, Dexcom and Abiomed. 

Seven members have been added to the Health Information Technology Advisory Committee (HITAC), a group tasked with improving the quality and access of health IT by the Government Accountability Office (GAO).

Healthcare stakeholders throughout U.S. medicine, including radiology leaders, aren’t waiting for the ink to dry before speaking their minds.

A molecular contrast agent previously cleared for use during surgery for ovarian cancer may now be used in similar fashion during lung operations.

Mahadevappa Mahesh, PhD, professor of radiology and a medical physicist at the Johns Hopkins University School of Medicine, explains a new ACR effort to ensure that lower radiation dose X-ray images under Image Wisely and As Low as Reasonable Achievable (ALARA) meet diagnostic reading standards.

The American Medical Association said its members are "extremely disappointed and dismayed" that Congress did not act in time. The Medical Group Management Association shared a similar message. 

The recall includes more than 2,000 devices distributed to customers in 2022. There have been 241 complaints, and 135 reported pump stops, related to this issue. 

Edward T.A. Fry, MD, president of the American College of Cardiology and a veteran cardiologist, shared his perspective on the many ways cardiologists can work to limit medical misinformation and disinformation.